Conversely, insulin-sensitizing strategies have been shown to improve memory performance, reduce cerebrospinal fluid biomarkers of disease, and enhance cerebral glucose utilization in mild cognitive impairment (MCI) and AD patients (Hölscher, 2014). This evidence concerns the gene INS and Alzheimer disease.